Fitt Insider

Joe Vennare

Fitt Insider is the show where we talk with the entrepreneurs, executives, and investors who are redefining the business of fitness and wellness.

  1. 6h ago

    363. Dustin Freckleton, Founder & CEO of Happy Health

    Today, I'm joined by Dustin Freckleton, founder & CEO of Happy Health.   A dark horse in the wearables race, Happy Health's FDA-cleared smart ring is designed to catch issues early and connect users with doctors for treatment.   In this episode, we discuss shifting healthcare from hospital to home.   We also cover: Cracking cuffless blood pressure monitoring N-of-1 AI algorithms and hyper-personalization Unlocking insurance coverage to expand access   Subscribe to the podcast → insider.fitt.co/podcast  Subscribe to our newsletter → insider.fitt.co/subscribe  Follow us on LinkedIn → linkedin.com/company/fittinsider    Website: happysleep.com  Follow Dustin: linkedin.com/in/dustinfreckleton  Follow Happy Health: linkedin.com/company/happyhealthinc    The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart fitness ecosystem for fitness and health facilities.   Fitt Talent: https://talent.fitt.co/  Consulting: https://consulting.fitt.co/  Investments: https://capital.fitt.co/    Chapters: (00:00) Introduction (01:22) Happy Health mission (02:30) Three-part platform explained (04:00) Why start with medical device approach (05:00) N-of-1 algorithm (08:00) Personalizing the experience (12:15) Role of physicians (17:45) Recent milestones (19:30) Building under the radar (22:00) Business model and insurance coverage (24:30) Blood pressure breakthrough (27:30) Why Happy solved what others couldn't (30:45) Multi-channel distribution strategy (32:00) Measuring what matters (36:15) Future of healthcare: data not models (40:15) Conclusion

  2. Oct 26

    362. Paul Coletta, Co-Founder & CEO of Vero Bioscience

    Today, I'm joined by Paul Coletta, co-founder & CEO of Vero Bioscience.   A predictive health company, Vero uses proteomic blood tests and proprietary AI to measure and improve organ-level aging.   In this episode, we discuss building a closed-loop health system powered by proteomics.   We also cover: Why organ-level data beats whole-body scores How proteomics differs from other biological age measures Reproducibility, clinical validation, and roadmap to launch Subscribe to the podcast → insider.fitt.co/podcast  Subscribe to our newsletter → insider.fitt.co/subscribe  Follow us on LinkedIn → linkedin.com/company/fittinsider    Get on the waitlist: verobioscience.com  X (Twitter): https://x.com/Vero_Bioscience Follow Paul: https://www.linkedin.com/in/paulcoletta Follow Vero: https://www.linkedin.com/company/vero-bioscience-inc  Eudaimonia (Health Innovation Lab) in November: https://eudemonia.net/hil/  YouTube: https://www.youtube.com/@VeroBioscience    The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart fitness ecosystem for fitness and health facilities.   Fitt Talent: https://talent.fitt.co/  Consulting: https://consulting.fitt.co/  Investments: https://capital.fitt.co/    Chapters: (00:00) Introduction (01:30) Paul's background (02:45) 11K protein measurement (04:00) Stanford technology (05:00) Scientific validation (06:00) Biological age vs. organ age (07:30) Actionability and reproducibility (10:00) Clinical validation approach (12:15) Closed-loop compass system (14:00) Organ-specific interventions (15:30) Healthspan vs. immortality (19:15) Clinical partnerships strategy (22:00) Competitive differentiation (25:00) Direct-to-consumer roadmap (27:30) Regulatory and cost challenges (28:30) Educating the market (30:00) Balancing rigor and marketing (34:00) Patient-led future (36:45) Conclusion

4.2
out of 5
10 Ratings

About

Fitt Insider is the show where we talk with the entrepreneurs, executives, and investors who are redefining the business of fitness and wellness.

You Might Also Like